Biotech & Pharma
Strategy & Commercialization

Our team of pharma business consultants provide deep knowledge in critical areas such as company and portfolio strategies, fundraising pitch materials, platform or program opportunity-feasibility assessments, new product planning, value-based pricing and market access, and product launch preparations.

Our Pharmaceutical Strategy & Commercialization Services

Business Plans
& Fundraising Support

A sound strategy is essential to healthcare investors at all stages of corporate development.


Gauge and rank the opportunities for your R&D programs or technology platforms to deliver value, by framing the commercial potential and charting the path to market.

New Product

Work with our experts to craft product strategies that are compelling to patients, providers, and payers.


Be ready for launch, on time and on budget, with the right people, processes and information for success.

Our strategy & commercialization capabilities

Whether you need guidance charting your optimal path to market, technical or market insight to prioritize your R&D portfolio, or strategic support to help you best position your biotech or program for a fundraising round, we can assist. Our consultants average 20-30 years of industry experience and bring significant first-hand knowledge to every project. 

Our core team leverages our Expert Network, which contains over 90 expert strategy and commercialization
 consultants who specialize in specific technologies and disease areas, allowing us to provide precisely relevant expertise across the below functional disciplines:

  • Business Analysis/Forecasting
  • Business Plans/Investor Pitch Decks
  • Commercial Strategy/Marketing
  • Market Access

  • Market Research 
  • Sales and Operations
  • Supply Chain


  • Autoimmune/Immunology
  • Cardiovascular
  • Central Nervous System
  • Congenital Disorders
  • Dermatology/Aesthetics
  • Digestive/GI
  • Ear
  • Endocrine and Metabolic
  • Fibrosis
  • Genitourinary Diseases
  • Haematology
  • Infectious Disease
  • Inflammation/Pain
  • Injuries and Trauma
  • Musculoskeletal
  • Non-medical
  • Oncology
  • Ophthalmology
  • Orphan Diseases
  • Respiratory
  • Urology (non-onc)
  • Women’s Health

Explore our Strategy & Commercialization Services

Contact Us

Reach out today for more information on our strategy & commercialization services.

Case Studies

Sales forecast in metastatic colorectal and gastric cancer

Challenge An international oncology drug development company is developing a bispecific product, currently in preclinical development. As an initial evaluation, our client wanted to...

Assessing the radiopharma landscape, future demand and competitive dynamics

Challenge A radiopharmaceuticals CDMO with activities in a range of therapeutic and diagnostic compounds including development-stage and commercial products asked Alacrita to assess the...

Bladder cancer: business case assessment

Challenge A group of healthcare investors with a long track record in the industry, but no biotechnology or research background, were interested in licensing a university project aimed at...

Assessing possible applications of an immunomodulatory therapy

Challenge: A biotech company developing immunomodulatory therapies asked Alacrita to assess the possible applications of its lead product, particularly in the context of improving the...

Assessing the potential of a novel extracellular vesicle technology

Challenge On behalf of an established Alacrita client, a publicly traded clinical stage biotechnology company with a cell therapy platform technology, we assessed the potential of a novel...

Opportunity mapping in advanced cholangiocarcinoma

Challenge A clinical-stage biotech company had an ongoing Phase 1 program exploring a combination therapy in multiple cancer types. The company wished to validate the addition of...